Join to view full profile
120 E Harris AveSan Angelo, TX 76903
Phone+1 325-653-6741
Dr. Parhizgar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amin Parhizgar is a nephrologist based in San Angelo, Texas, with a subspecialty in interventional nephrology. After graduating from Pahlavi University of Medical Sciences in 2002 with an MD, Dr. Parhizgar completed a residency in Internal Medicine at Penn State Milton S Hershey Medical Center from 2008-2011, as well as nephrology fellowships at both the University of Texas Southwestern Medical Center (2011-2013) and the University of Alabama Birmingham. Dr. Parhizgar has also published in the Iranian Journal of Kidney Diseases, Skin Pharmacology and Physiology, and Dermatology, with each publication being widely cited in other works.
Education & Training
University of Alabama at BirminghamFellowship, Interventional Nephrology, 2013 - 2014
University of Texas Southwestern Medical CenterFellowship, Nephrology, 2011 - 2013
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2008 - 2011- Pahlavi University of Medical SciencesClass of 1995, MD
Certifications & Licensure
TX State Medical License 2013 - 2028
AL State Medical License 2013 - 2014
PA State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
National Board of Physicians and Surgeons Internal Medicine- National Board of Physicians and Surgeons Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification InteGreat® EHR, McKesson, 2016-2017
Publications & Presentations
PubMed
- 12 citationsEffect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney diseaseChristin Spatz, Lawand Saadulla, Apurva Lapsiwala, Amin Parhizgar, Nasrollah Ghahramani
Iranian Journal of Kidney Diseases. 2012-11-01 - 18 citationsSafety of topical methimazole for the treatment of melasma. Transdermal absorption, the effect on thyroid function and cutaneous adverse effects.Behrooz Kasraee, G.H. Safaee Ardekani, A. Parhizgar, Farhad Handjani, Gholamhossein Ranjbar Omrani
Skin Pharmacology and Physiology. 2008-07-31 - 29 citationsTopical Methimazole as a New Treatment for Postinflammatory Hyperpigmentation: Report of the First CaseBehrooz Kasraee, Farhad Handjani, A. Parhizgar, Gholamhosein R. Omrani, Mohammad Reza Fallahi
Dermatology. 2005-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
